Veterinary Medicines

PARVORUVAX, injekcinė suspensija kiaulėms

Authorised
  • Erysipelothrix rhusiopathiae, serotype 2, Inactivated
  • Porcine parvovirus, strain K22, Inactivated
Download as PDF

Product identification

Medicine name:
PARVORUVAX, injekcinė suspensija kiaulėms
Active substance:
  • Erysipelothrix rhusiopathiae, serotype 2, Inactivated
  • Porcine parvovirus, strain K22, Inactivated
Target species:
  • Pig
Route of administration:
  • Intramuscular use

Product details

Active substance and strength:
  • Erysipelothrix rhusiopathiae, serotype 2, Inactivated
    1.00
    enzyme-linked immunosorbent assay unit
    /
    1.00
    Dose
  • Porcine parvovirus, strain K22, Inactivated
    2.00
    haemagglutination inhibiting unit(s)
    /
    1.00
    Dose
Pharmaceutical form:
  • Suspension for injection
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI09AL01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription except for some pack sizes
Authorisation status:
  • Valid
Authorised in:
  • Lithuania
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Legal basis reviewed according to Acquis communautaire
Marketing authorisation holder:
  • Ceva Sante Animale
Marketing authorisation date:
Manufacturing sites for batch release:
  • Boehringer Ingelheim Animal Health France
Responsible authority:
  • State Food And Veterinary Service
Authorisation number:
  • LT/2/02/1375/001-003
Date of authorisation status change:

Documents

RV1375.pdf

Lithuanian (PDF)
Published on: 10/09/2025
Download